Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440)
Status:
Terminated
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
Subjects will be given 3 infusions of infliximab according to the label at week 0, 2, and 6.
Subjects will be followed for a maximum of 18 weeks or until relapse. This study will assess
the ability of the Power Doppler Ultrasonography (PDUS) to be a reliable marker of enthesitis
response and relapse in subjects treated with infliximab.